Current Edition

Collaborating with Patients for Better Trial Design
Editorial Archive

Collaborating with Patients for Better Trial Design

Modern patients are taking control of their own healthcare, from sharing information with one another to approaching industry organisations with their concerns. Tarqu...
Continue Reading →
Patient-centricity: A Progressive Prescription for Modern  Healthcare
Editorial Archive

Patient-centricity: A Progressive Prescription for Modern Healthcare

A revolution is happening in the healthcare industry. Societal pressure to improve our health, technological advances, and market forces are all driving forward a nov...
Continue Reading →
Seeing Beyond the Label: Transforming the Management of  Customer Materials
Editorial Archive

Seeing Beyond the Label: Transforming the Management of Customer Materials

Integration and increased automation are transforming the way life sciences companies manage much of their operational and regulatory information. Labelling and packa...
Continue Reading →
Early-stage Development, Xcelodose & Clinical Phases
Editorial Archive

Early-stage Development, Xcelodose & Clinical Phases

The pharmaceutical industry’s ongoing demand to shorten drug development times, thus making significant cost savings, is driving technological advances forward at the...
Continue Reading →
Driving by Data: A Faster, Better Road to Market
Editorial Archive

Driving by Data: A Faster, Better Road to Market

The clinical development path is rife with complexity that can stall or stop a drug’s journey to market. Paul Evans, Jeetendra Rao and Abigaile Betteridge at PAREXEL ...
Continue Reading →
Enrolment Compliance and Study Data
Editorial Archive

Enrolment Compliance and Study Data

The current concept of clinical trial conduct is a balance between benefits from treatment (efficacy) and risks that this treatment may have (risk). Maxim Kosov, Tati...
Continue Reading →
Clinical Development in Challenging Cancers: Primary Bone  Sarcomas
Editorial Archive

Clinical Development in Challenging Cancers: Primary Bone Sarcomas

Primary bone sarcomas are cancers of mesenchymal, non-epithelial derivation, originating from bone cells or their precursors. Kelechi K. Olu MD, MSc, Vijayanand Rajen...
Continue Reading →
Three Respiratory Trial Strategies that Won’t Leave You  Breathless
Editorial Archive

Three Respiratory Trial Strategies that Won’t Leave You Breathless

The biopharmaceutical industry invests billions of dollars annually into clinical research to address a range of debilitating respiratory conditions. Phil Lake at ERT...
Continue Reading →
Augmenting Clinical Development of Heart Failure Therapies
Editorial Archive

Augmenting Clinical Development of Heart Failure Therapies

There are currently a number of pharmaceutical or device-based heart failure therapies in clinical use, with numerous promising candidates under development. Bobby St...
Continue Reading →
Potential Therapies in the R&D Pipeline for  Facioscapulohumeral Muscular Dystrophy
Editorial Archive

Potential Therapies in the R&D Pipeline for Facioscapulohumeral Muscular Dystrophy

Facioscapulohumeral MD, likely the most prevalent form of MD, currently has no cure, but several factors point to the potential for successful development of a diseas...
Continue Reading →